• Regeneron Pharmaceuticals average ebitda margin for 2023 was 36.37%, a 26% decline from 2022.
• Regeneron Pharmaceuticals average ebitda margin for 2022 was 49.15%, a 9.28% decline from 2021.
• Regeneron Pharmaceuticals average ebitda margin for 2021 was 54.18%, a 31.5% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.